Stay updated on ADXS-503 & Pembro in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.

Latest updates to the ADXS-503 & Pembro in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the previous government funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice banner about NIH operations and a new revision tag (v3.4.1); the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary toggle is now visible and two metadata labels have updated capitalization (Last Update Submitted that Met QC Criteria; No FEAR Act Data). The revision label has changed from v3.3.4 to v3.4.0, indicating a minor update.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated 'Locations' section listing participating sites by state (CA, GA, IL, KS, NJ, NY, OR, VA). Removed the old per-state 'Locations' headers and the 'HHS Vulnerability Disclosure' link.SummaryDifference0.9%

- Check92 days agoChange DetectedFooter revision log updated: added Revision v3.3.2 and removed Revision v3.2.0; no substantive changes to study details, eligibility, contacts, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ADXS-503 & Pembro in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADXS-503 & Pembro in Lung Cancer Clinical Trial page.